Netflix Shares Face Headwinds from Major Acquisition and Regulatory Scrutiny

Netflix US64110L1061

Netflix's stock came under significant pressure following its latest earnings report, closing at $83.54, a decline of 2.13%. Trading activity was notably elevated, with approximately 67 million shares changing hands, well above the three-month average. This market reaction came despite the streaming giant posting fourth-quarter 2025 results that exceeded analyst forecasts, highlighting investor concerns centered on its growth outlook and a massive pending acquisition.

The company reported robust financials for Q4 2025. Revenue reached $12.05 billion, an 18% year-over-year increase and slightly ahead of the consensus estimate of $11.97 billion. Earnings per share came in at $0.56, narrowly surpassing the expected $0.55. Subscriber numbers climbed to over 325 million, reinforcing Netflix's dominant position in the streaming sector. A key growth driver was its advertising business, which generated more than $1.5 billion in revenue for 2025, with management targeting a doubling to roughly $3 billion in 2026.

However, the company's forward guidance introduced a note of caution. For the full year 2026, Netflix projected revenue growth of 12% to 14%, a noticeable deceleration from the approximately 16% growth achieved in 2025 and below prior market expectations.

In response, several analyst firms revised their price targets downward:
- Bernstein Research maintained an "Outperform" rating but lowered its target from $125 to $115, citing margin risks.
- Argus cut its target from $141 to $110.
- New Street Research reduced its target to $96.

The Warner Bros. Discovery Deal: A High-Stakes Gamble

The primary source of market anxiety is Netflix's proposed acquisition of key studio and streaming assets from Warner Bros. Discovery (WBD). Netflix has revised its merger agreement, now offering $27.75 per WBD share in an all-cash deal, valuing the transaction at approximately $82.7 billion. This shift to a pure cash offer aims to eliminate uncertainty for WBD shareholders related to stock-based components.

Competition complicates the process. Rival bidder Paramount Skydance remains in contention with a hostile offer of $30 per WBD share, implying an enterprise value of $108.4 billion. This offer has been extended until February 20, 2026. The intensified bidding war increases pressure on Netflix, with the final terms and success of the acquisition remaining uncertain.

Regulatory Hurdles and Financial Implications

The stock's current weakness occurs amidst a broader correction; shares now trade about 38% below their June 2025 record high of $133.91. Operationally, the business remains solid, with Netflix guiding for a 2026 operating margin of 31.5%.

Financing the nearly $83 billion deal has led Netflix to suspend its share buyback program, removing a key supportive factor for the stock price. Furthermore, significant political and regulatory scrutiny is emerging. It was confirmed that Co-CEO Ted Sarandos will testify before a U.S. Senate subcommittee in February regarding the antitrust implications of the transaction. Senators such as Mike Lee and Elizabeth Warren have publicly labeled the potential combination a possible "anti-monopoly nightmare" scenario, amplifying perceived risks.

While Netflix brings a substantially larger subscriber base of 325 million to the table, WBD contributes extensive studio infrastructure alongside a significant debt load. Integrating these assets is complex, especially as the market shifts focus from pure subscriber growth to profitability and consolidation. Netflix's strategic aim is to strengthen its position in long-form content against platforms like YouTube and TikTok.

Key Catalysts on the Horizon

The coming weeks will be shaped by two critical events. First, Ted Sarandos's Senate testimony in February will provide clues into the regulatory appetite for the deal. Second, the expiration of the Paramount Skydance offer for WBD on February 20, 2026, represents a decisive moment in the bidding process.

Despite the recent price target reductions, the overall analyst sentiment remains cautiously positive. The consensus rating stands at "Moderate Buy" with an average price target of around $119, suggesting meaningful upside potential should the transaction succeed and associated risks be managed. From a technical perspective, the stock is testing a support zone near $83; a break below this level could invite further selling pressure, while progress on regulatory and M&A fronts is a prerequisite for a sustained recovery.